Pay in 4 interest-free payments of $6.54 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
New therapies for obesity
smaller doses, titration guidance, and what to discuss with your provider
This was compared to people taking a placebo, who lost an average of 3.1% of their starting body weight
We specifically adjust our treatments to work best for your body
A GLP-1/glucagon (GCG)/CCK2 receptors tri-agonist provides new therapy for obesity and diabetes
The startup, which focuses on psychology-driven weight loss with behavior coaching, last raised $540 million in Series F funding in 2021 at a $3.7 billion valuation
US$ 26.09
US$ 24.82
US$ 21.30
US$ 22.49
US$ 29.47
US$ 23.38
US$ 23.22
US$ 28.62
US$ 26.10
US$ 23.24
